⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Relapse Determinants in Seropositive and Seronegative Neuromyelitis Optica Spectrum Disorder (P10-14.016)

Pakeeran Siriratnam Paul G. Sanfilippo Saif Huda Sifat Sharmin Tomáš Kalinčík Anneke van der Walt Vilija Jokubaitis Helmut Butzkueven Mastura Monif

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the predictors of relapses in seropositive and seronegative neuromyelitis optica spectrum disorder (NMOSD).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Siriratnam et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db6435876781cc https://doi.org/10.1212/wnl.0000000000205576

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Relapse And Non-relapse Hospitalizations in Neuromyelitis Optica Spectrum Disorders (NMOSD) (P8-15.004)2024
2Risk Factors Associated with Disability and Recurrence of Relapses in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) Attended in a Neuroinmunology Unit of a Therthiary Health Care Center at the Dominican Republic During October 2024–January 2025.- (P2-2.010)Original Research · 2026
3Clinical and Radiological Features of Neuromyelitis Optic Spectrum Disorder with and Without Identifiable Triggers (P2-2.008)Original Research · 2026
4Depression and Anxiety in Neuromyelitis Optica Spectrum Disease (NMOSD): Analysis of a National Dataset (P10-14.007)2024
5Frequency of Neuromyelitis Optica Spectrum Disorder Correlated Symptoms: A Pre- and Post-diagnosis Comparison from a National Dataset (P10-14.011)2024